Restricted accessCase reportFirst published online 2012-8
Favourable outcome of progressive multifocal leukoencephalopathy with mefloquine treatment in combination with antiretroviral therapy in an HIV-infected patient
A 33-year-old man who developed progressive multifocal leukoencephalopathy (PML) with HIV infection is reported. The patient exhibited rapid decline in neurological status after initiation of antiretroviral therapy (ART), which was attributed to the PML-immune re-constitution inflammatory syndrome. Following the administration of mefloquine in combination with ART, the patient's neurological status improved substantially. This case suggests that further investigation of the use of mefloquine might be warranted for treatment of PML in HIV-infected patients.
CettomaiD, McArthurJC. Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy. Arch Neurol2009;66:255–8
2.
BrickelmaierM, LugovskoyA, KartikeyanR, Identification and characterization of mefloquine efficacy against JC virus in vitro. Antimicrob Agents Chemother2009;53:1840–9
3.
BerenguerJ, MirallesP, ArrizabalagaJ, Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy. Clin Infect Dis2003;36:1047–52
4.
GoftonTE, Al-KhotaniA, O'FarrellB, AngLC, McLachlanRS. Mefloquine in the treatment of progressive multifocal leukoencephalopathy. J Neurol Neurosurg Psychiatry2011;82:452–5
5.
KishidaS, TanakaK. Mefloquine treatment in a patient suffering from progressive multifocal leukoencephalopathy after umbilical cord blood transplant. Intern Med2010;49:2509–13
6.
MarzocchettiA, TompkinsT, CliffordDB, GandhiRT, KesariS, BergerJR. Determinants of survival in progressive multifocal leukoencephalopathy. Neurology2009;73:1551–8
7.
TanK, RodaR, OstrowL, McArthurJ, NathA. PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids. Neurology2009;72:1458–64
8.
Du PasquierRA, KoralnikIJ. Inflammatory reaction in progressive multifocal leukoencephalopathy: harmful or beneficial?J Neurovirol2003;9(Suppl. 1):25–31
